Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer
BackgroundThis study aimed to evaluate the efficacy and safety of pyrotinib in the treatment of HER2-positive breast cancer patients with and without liver metastasis.MethodsA retrospective analysis was conducted on 91 patients with HER2-positive advanced breast cancer, who were treated with pyrotin...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2025-04-01
|
| Col·lecció: | Frontiers in Oncology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1527277/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|